Amyris acquiring Terasana brand to offer clean cannabinoid consumer products

In California, Amyris, Inc. will expand its portfolio of consumer brands by launching a new range of Terasana branded clean beauty products focused on sustainably sourced natural cannabinoids, enabled by its proprietary Lab-to-Market synthetic biology platform, which has a track record of developing and producing platform molecules from naturally sourced sugarcane and a sustainable fermentation production process. Through this platform, Amyris recently commercialized a clean, sustainable, fermentation based CBG (cannabigerol), a non-psychoactive cannabinoid.

The addition of Terasana will further expand Amyris’s presence in the clean beauty space beyond its Biossance skincare, Pipette baby and mother care, Rose Inc. clean cosmetics brand and recently announced Jonathan Van Ness partnership for a new clean haircare brand.

“We are very pleased with the early clinical results demonstrating Amyris CBG benefits including enhanced performance when combined with squalane. We are excited to lead the cannabinoid industry with science-backed, sustainably and cost-effectively sourced minor cannabinoids delivering outstanding performance for consumers and our planet,” said John Melo, President and Chief Executive Officer of Amyris. “During the fourth quarter of 2020 we sold out our entire first industrial production of clean CBG as an ingredient for use in flavors and fragrances. We are very optimistic about the future of clean cannabinoids and the efficacy they can bring to skincare as a logical extension to our existing consumer portfolio. Amyris’s consumer business is nearly half of total product revenue and represents the fastest growing business activity in our portfolio.”